Dry Powder Inhaler Device Market Size, Share & Trends | Industry Report, 2018-2026
Increase in ageing population who are prone to or
has risk of respiratory infections will boost market growth; increasing
incidences of hereditary diseases, lung disorders and increasing pollution due
to the high discharge of harmful chemicals are significant reasons for chronic
respiratory diseases and are the major factors influencing the growth of market
for dry powder inhaler devices.
Market Size – USD 643.1 Million in 2018, Market Growth
- CAGR of 4.4%, Market Trends –Increase in ageing population globally who are
prone to respiratory infections.
The global Dry Powder Inhaler Device Market is
estimated to reach USD 912.3 Million by 2026, according to a new report by
Reports and Data. This can be mainly associated due to increasing incidences of
hereditary diseases, lung disorders and increasing pollution due to the high
discharge of harmful chemicals are significant reasons for chronic respiratory
diseases that are generating a significant demand for the dry powder inhalers.
Improvised efficiency of dry powder inhalers and better results in comparison
with alternative therapies is a driving factor that will aid market growth.
Based on statistics, the rise in elderly population base inclined to
respiratory infections will boost market growth. A significant cause of lung
disorders in teenagers and adults is the addiction to nicotine. Increases in variations
of hormones due to the changing lifestyle which can trigger the need for having
an addiction are also significant factors stimulating Market demand.
Dry powder inhaler market in North America accounts
for the largest share of 22.30% in 2018, which is driven due to the
presence of world-class healthcare infrastructure with technologically advanced
practice, a high number of people with respiratory problems, higher spending,
strict guidelines and presence of leading industry players in the region. The
U.S. will boost the North America dry powder inhaler industry due to the
increasing predominance of asthma and other respiratory diseases copulated with
the growing geriatric population. Adoption of new technologies will further
propel the growth of dry powder inhaler devices.
Further key findings from the report suggest
- The asthma segment is valued at USD 205.1
million in 2018 and is estimated to reach USD 299.2 million by 2026 at a
CAGR of 4.7% during the forecast period, due to an increase in air
pollution levels across the world and increase in the incidence of asthma
particularly in developed countries.
- Single-use devices are observing improved
demand as they have the potential to overcome the challenges and offer a
hygienic & clean device. This segment is valued at USD 393.5 million
in 2018 and is estimated to reach USD 563.8 million by 2026 at a CAGR of
4.5% during the forecast period. A significant trend in the market is the
demand for accessibility and easy handling of respiratory devices.
- Multiple dry powder inhalers are popular among
patients with respiratory diseases as an additional device for different
places such as cars, homes and job sites. With single-use dry powder
inhalers, patients are allowed to carry the exact dose of inhalations
needed in blister packs, which in turn promotes handling and comfort.
- The chronic obstructive pulmonary diseases
(COPD) sector of the application segment accounts for a market share of
21.50% in 2018 and is estimated to reach USD 202.5 million by 2026 at a
CAGR of 4.8%.
- Increase in incidence of respiratory disorders
including asthma and COPD, increase in air pollution levels especially in
emerging countries, and an increase in per capita health care spending are
the major factors increasing demand and utilization of dry powder inhalers
worldwide.
- Increase in variations of hormones due to the
changing lifestyle which can trigger the need for having an addiction will
show enhanced demand for dry powder inhaler industry growth.
- The rise in the number of prescriptions for
dried powder inhalers by hospitals due to the growth rate of adoption
shown by doctors boost the market growth. Among the end users segment, the
hospital sector is anticipated to grow at a CAGR of 4.6%. IT accounts for
the largest market share of 46.41% in 2018. The growth in this market
segment is due to the availability of these inhalers in the pharmacies and
presence of strong business channels.
- Lifestyle changes and rise in the occurrence
of allergies and infections amongst the population has driven to an
extended demand for dry powder inhalers in the overall market in Europe.
Industrialization and excessive use of chemicals have further increased
the occurrence of respiratory ailments in workers that have led to market
development.
- Other regions such as APAC are estimated to
register the highest CAGR of 5.1 %, during the forecast period. APAC is
anticipated to have the fastest growth, due to a rapidly emerging medical
infrastructure, increasing expenses on healthcare and rising medical
tourism in developing nations such as China and India in this region.
- Key participants include 3M Company, Astrazeneca
Plc., Chiesi Farmaceutici S.p.A., GlaxoSmithKline Plc, Novartis AG, Cipla
Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH,
MannKind Corporation, and Vectura Group Plc.
For the purpose of this report, Reports and Data
have segmented global Dry Powder Inhaler Device Market on the basis of Type,
Product, Application, End Users and region:
Product Outlook (Volume, Thousand Units; and
Revenue, USD Million; 2016-2026)
- Capsule based
- Blister based
- Reservoir/Cartridge based
- Others
End User Outlook (Volume, Thousand Units; and
Revenue, USD Million; 2016-2026)
- Hospitals and pharmacies
- Retail pharmacies
- Drug stores
Application Outlook (Volume, Thousand Units; and
Revenue, USD Million; 2016-2026)
- Asthma
- COPD
- Diabetes
- Hereditary diseases
- Other
Type Outlook (Volume, Thousand Units; and Revenue,
USD Million; 2016-2026)
- Single dose
- Multi-dose
Regional Outlook (Volume, Kilo Tons; and Revenue,
USD Million; 2016-2026)
- North America
- U.S.
- Europe
- Germany
- UK
- Asia Pacific
- China
- India
- South-east Asia
- Latin America
- Brazil
- MEA
Browse More Reports of Medical
Devices Category At: https://www.reportsanddata.com/report/category/medical-devices
Comments
Post a Comment